These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31980112)

  • 21. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 23. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do-it-yourself closed-loop systems for people living with type 1 diabetes.
    Dowling L; Wilmot EG; Choudhary P
    Diabet Med; 2020 Dec; 37(12):1977-1980. PubMed ID: 32420640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
    Jarosinski MA; Dhayalan B; Rege N; Chatterjee D; Weiss MA
    Diabetologia; 2021 May; 64(5):1016-1029. PubMed ID: 33710398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 21st century diabetes care: a marriage between humans and technology.
    Murphy HR
    Trends Endocrinol Metab; 2013 May; 24(5):219-21. PubMed ID: 23375387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes Technology.
    Pfützner A
    Endocr Dev; 2016; 31():57-83. PubMed ID: 26824436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes Technology: Monitoring, Analytics, and Optimal Control.
    Kovatchev B
    Cold Spring Harb Perspect Med; 2019 Jun; 9(6):. PubMed ID: 30126835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HbA
    Carlson AL; Criego AB; Martens TW; Bergenstal RM
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):95-107. PubMed ID: 31980124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.
    Graf A; McAuley SA; Sims C; Ulloa J; Jenkins AJ; Voskanyan G; O'Neal DN
    J Diabetes Sci Technol; 2017 Mar; 11(2):308-314. PubMed ID: 28264192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY; Haviland N; Bailey TS
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes Technology Meeting 2023.
    Tian T; Aaron RE; DuNova AY; Jendle JH; Kerr D; Cengiz E; Drincic A; Pickup JC; Chen KY; Schwartz N; Muchmore DB; Akturk HK; Levy CJ; Schmidt S; Bellazzi R; Wu AHB; Spanakis EK; Najafi B; Chase JG; Seley JJ; Klonoff DC
    J Diabetes Sci Technol; 2024 Sep; 18(5):1208-1244. PubMed ID: 38528741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Glucagon in Automated Insulin Delivery.
    Wilson LM; Jacobs PG; Castle JR
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
    Kravarusic J; Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern diabetes devices in the school setting: Perspectives from school nurses.
    March CA; Nanni M; Kazmerski TM; Siminerio LM; Miller E; Libman IM
    Pediatr Diabetes; 2020 Aug; 21(5):832-840. PubMed ID: 32249474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipohypertrophy Effect on Glycemic Profile in an Adult With Type 1 Diabetes Using Scanned Continuous Glucose Monitoring.
    Oriot P; Hermans MP
    J Diabetes Sci Technol; 2020 Mar; 14(2):500-501. PubMed ID: 31847568
    [No Abstract]   [Full Text] [Related]  

  • 39. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in diabetes technology within the digital diabetes ecosystem.
    Akturk HK; Bindal A
    J Manag Care Spec Pharm; 2024 Oct; 30(10-b Suppl):S7-S20. PubMed ID: 39347970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.